期刊文献+

2型糖尿病肾病的载脂蛋白E基因多态性研究 被引量:5

Study on apolipoprotein E polymorphism of type 2 diabetes mellitus with nephropathy
下载PDF
导出
摘要 目的 研究载脂蛋白E(ApoE)基因多态性与 2型糖尿病肾病的关系。方法 采用聚合酶反应 (PCR)和限制性片段、长度多态性分析 (RFLP)技术 ,研究 5 8例 2型糖尿病肾病患者、5 6例 2型糖尿病未合并肾病患者和 76例正常对照者载脂蛋白 (ApoE)的基因多态性。 结果 ① 2型糖尿病肾病患者ε2 等位基因频率 (14 6 % )高于 2型糖尿病非肾病患者 (3 6 % ) (P <0 0 1,χ2 =8 37)和正常对照者 (5 7% ) (P<0 0 5 ,χ2 =4 2 8) ,3组中ε3 和ε4等位基因频率差异无显著性 (P >0 0 5 )。②携带ε2 等位基因的 2型糖尿病患者TG水平较携带ε3 和ε4等位基因的 2型DM患者增高 (P <0 0 1vsP <0 0 5 ) ,而LDL C水平降低 (P <0 0 5 ) ,携带ε4等位基因的 2型DM患者 ,其TC和LDL C水平较携带ε2 和ε3 等位基因的个体增高 (P <0 0 1)。③ApoE基因多态性在男女性别上差异无显著性 (P >0 0 5 )。结论 ApoE基因多态性与 2型糖尿病肾病的发生有关 ,提示ε2 等位基因频率越高 ,发生 Objective To investigate the relationship b et ween the genetic polymorphism of apolipoprotein E and type 2 diabetic nephropath y. Methods The genetic polymorphism of apolipoprotein E in 58 t ype 2 diabetic patients with nephropathy, 56 type 2 diabetic patients without ne phropathy and 76 normal controls were observed by the method of polymerase chain reaction restriction fragment length polymorphism.Results ① The ε 2 allele frequency of type 2 diabetic patients with nephropathy (14 6 % ) was significantly higher than that of type 2 diabetic patients without nephrop athy (3 6%) ( P <0 01 χ 2=8 37) and normal controls(5 7%) ( P <0 05 χ 2=4 28). There were no significant differences of ε 3 and ε 4 allele fr equencies between the groups.( P >0 05). ② The level of plasma TG of type 2 diabetic patients with ε 2 allele was significantly higher than that of ty pe 2 diabetic patients with ε 3 allele or ε 4 allele ( P<0 01 vs P <0 0 5 ), while the level of plasma LDL C was significantly lower than that of type 2 d iabetic patients with ε 3 or ε 4 allele ( P <0 05). The levels of plasma TC and LDL C of type 2 diabetic patients with ε 4 allele were significantly higher than those of type 2 diabetic patients with ε 2 or ε 3 allele( P <0 01). ③ There was no significant difference of ApoE genetic polymorphism bet ween male and female ( P >0 05) Conclusion Apolipoprotein E polymorphism is related to type 2 diabetic nephropathy.ε 2 allele is a risk factor for type 2 diabetic nephropathy.
出处 《安徽医科大学学报》 CAS 2002年第4期286-289,共4页 Acta Universitatis Medicinalis Anhui
关键词 2型糖尿病肾病 载脂蛋白E 基因多态性 diabetic nephropathies apolipoprotein E diabetes mellit us, non insulin dependent polymerase chain reaction
  • 相关文献

参考文献14

  • 1[1]Mulee H,Johnson S,Bjorck S.Relation between serum cholesterol and diabetic nephropathy.Lancet,1990; 335(4):1537~1538
  • 2[2]Kasiske BL,O'Donnell M,Cleary MP et al.Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats.Kidney Int,1989;35(3):40~48
  • 3[3]ADA.Diagnosis and treatment of diabetic nephropathy.For the 120 million diabetics worldwide.1996;7:7~8
  • 4[4]Hixson JE,Vernier DT.Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I.J Lipid Res,1990;31(1):545
  • 5[5]Richard P,Thomas G,Zulueta MP et al.Common and rate genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.Clin chem,1994;40(6):24
  • 6[6]Moorhead JF,Chan MK,Nahas M et al.Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease.Lancet,1982;279(2):1309~1311
  • 7[7]Diamond JR,Hanchak NA,Mocarter MD et al.Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.Am J Clin Nutr,1990;51(5):606
  • 8[8]Harris KPG,Purkerson ML,Yates J et al.Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.Am J Kidney Dis,1990;15(6):16
  • 9[9]Eto M,Watanaba K,Sato T et al.Aplipoprotein E2 and hyperlipoproteinemia in NIDDM.J Clin Endocrinol Metab,1998;69(3):1207~1212
  • 10[10]Oikawa S,Suzuki N,Sakuma E et al.Abnormal lipoprotein and apolipoprotein in lipoprotein glomerulopathy.Am J Kidney Dis,1991;18(5):553~558

同被引文献71

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部